Cellular Dynamics is a leader in the production of iPS-based cells such as cardiomyocytes, hepatocytes etc., used for drug testing and other purposes. CDI was founded in 2004 and listed on NASDAQ in July 2013. The company had global revenues of $16.7 million in the year ended, December 31, 2014 and had 155 employees as of December 31, 2014.

CDI press release, March 31, 2015